A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer
Clinical trial NCT04282031 · RECRUITING
Trial details
- NCT number
- NCT04282031
- Sponsor
- Beta Pharma (Suzhou) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-15
- Primary completion
- 2024-12-31
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.